Regen BioPharma Inc (RGBP)

[cvinvestor]

Like Kfox mentioned again today, without news of partnerships or funding, we go nowhere on Koos' or Lander's news. Why don't they put in the PR how these things were discovered, such as "our research program with NCATs has been successful with multiple hits for compounds..." or if not NCATs, then "Our recent enrollment in Eli Lilly's compound drug research program is proving very fruitful for the company..."

Since we don't hear of C. Ichim anymore, who and where are these "discoveries" coming from and why should the source be such a secret if they want partnerships from larger entities?

They give us statements and news which, if true, is very good news indeed, but without the reasons and sources, it lacks depth and impact. I think if either NCATS or Eli - Lilly programs are where this is being validated, then mentioning that fact in the PR would go a long way in generating more interest and investment.

Of course, unless we tie a reverse split into a major news/partnership deal, the larger investment firms can't come in anyway, so we seem to have a long way to go. Certainly, it can turn in a day, but when Koos and Landers release PRs that don't give basic facts of when, how, where, they don't seem to have much effect.


Koos isn't making these discoveries and I don't think Lander is the scientist behind it all, so why not mention who and where and create some buzz? Unless they are worried that the IP would be highly susceptible to leakage as a result, it would be nice to know how all this is coming about.

Haven't heard from Kesari, dCellVax data in a long time and we are beyond the 3 month check point for the HemaX results in Mexico. Should still be more news coming this month.

And oh, still no news on the Orphan Drug Status filing from January. The fact the company doesn't seem interested in keeping those following the company updated and these types of things also leaves questions as to what is really going on.